Vineet Laboratories Reports Zero Deviation in Rights Issue Fund Utilization
Vineet Laboratories Ltd · Others (Uncategorized) · 27 Oct 2026, 12:36 am
Vineet Laboratories Reports Zero Deviation in Rights Issue Fund Utilization Vineet Laboratories confirmed no deviation or variation in utilizing proceeds from its ₹2,996.81 Lakhs equity rights issue for the quarter ended 30th Jun'26. Monitored by Crisil Ratings, the company fully deployed ₹284 Lakhs toward bank loan repayments and utilized ₹670.66 Lakhs of the allocated ₹670.83 Lakhs for general corporate purposes. Additionally, ₹33.75 Lakhs has been spent toward the ₹270 Lakhs effluent treatment plant project, and ₹293.65 Lakhs has been invested out of ₹1,695.35 Lakhs allocated for setting up new production facilities.
Original exchange filing (PDF)
More announcements from Vineet Laboratories Ltd
- Intimation-Newspaper publication of finaancial results of the quarter and half year ended 30.09.2026. · 16 Nov 2026
- Statement of Deviation & Variation for September 30 2026 quarter · 13 Nov 2026
- Results for the quarter and half year ended 30.09.2026 · 12 Nov 2026
- Results for the quarter and Half year ended 30.09.2026 · 12 Nov 2026
- Vineet Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 12 Nov 2026
- Intimation of book closure regarding 10th Annual General Meeting · 07 Nov 2026
- Notice of 10th Annual general meeting of the company. · 07 Nov 2026
- Submission of Annual report for the FY 2025-26 · 07 Nov 2026
